Rheumatoid Arthritis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

Rheumatoid Arthritis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

Summary

Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Rheumatoid Arthritis - Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update, provides an overview of the Rheumatoid Arthritis (Immunology) pipeline landscape.

Rheumatoid arthritis (RA) is an autoimmune chronic disorder that eventually leads to destruction of bones causing deformities. Signs and symptoms of rheumatoid arthritis include tender, warm, swollen joints, fatigue, and fever and weight loss. Rheumatoid arthritis may be a result of genetic and certain specific environmental factors. Women are much more susceptible to develop RA. Treatment includes non-steroidal anti-inflammatory drugs, corticosteroid medications and immunosuppressants.

Report Highlights

Global Markets Direct's Pharmaceutical and Healthcare latest pipeline guide Rheumatoid Arthritis - Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update, provides comprehensive information on the therapeutics under development for Rheumatoid Arthritis (Immunology), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

The Rheumatoid Arthritis (Immunology) pipeline guide also reviews of key players involved in therapeutic development for Rheumatoid Arthritis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Pre-Registration, Filing rejected/Withdrawn, Phase III, Phase II, Phase I, IND/CTA Filed, Preclinical, Discovery and Unknown stages are 12, 2, 24, 47, 89, 9, 216, 68 and 9 respectively. Similarly, the Universities portfolio in Phase III, Phase I, Phase 0, Preclinical and Discovery stages comprises 1, 5, 1, 28 and 2 molecules, respectively.

Rheumatoid Arthritis (Immunology) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Global Markets Direct’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

Note:Certain content / sections in the pipeline guide may be removed or altered based on the availability and relevance of data.

Scope

• The pipeline guide provides a snapshot of the global therapeutic landscape of Rheumatoid Arthritis (Immunology).
• The pipeline guide reviews pipeline therapeutics for Rheumatoid Arthritis (Immunology) by companies and universities/research institutes based on information derived from company and industry-specific sources.
• The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
• The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
• The pipeline guide reviews key companies involved in Rheumatoid Arthritis (Immunology) therapeutics and enlists all their major and minor projects.
• The pipeline guide evaluates Rheumatoid Arthritis (Immunology) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
• The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
• The pipeline guide reviews latest news related to pipeline therapeutics for Rheumatoid Arthritis (Immunology)

• Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
• Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
• Find and recognize significant and varied types of therapeutics under development for Rheumatoid Arthritis (Immunology).
• Classify potential new clients or partners in the target demographic.
• Develop tactical initiatives by understanding the focus areas of leading companies.
• Plan mergers and acquisitions meritoriously by identifying key players and it’s most promising pipeline therapeutics.
• Formulate corrective measures for pipeline projects by understanding Rheumatoid Arthritis (Immunology) pipeline depth and focus of Indication therapeutics.
• Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
• Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.

Companies Mentioned
Companies Mentioned

180 Life Corp
3SBio Inc
4D Pharma Plc
AB Science SA
AbbVie Inc
Abcentra LLC
Abclon Inc
Abivax SA
Ablynx NV
Abwiz Bio Inc
Accro BioScience (Suzhou) Co Ltd
Aclaris Therapeutics Inc
Adare Pharma Solutions
Affilogic SAS
Ahead Therapeutics SL
AIBIOS Co Ltd
AimVion AS
Akari Therapeutics Plc
Alibion AG
Allied-Bristol Life Sciences LLC
Alphamab Oncology
Alpine Immune Sciences Inc
Aluda Pharmaceuticals Inc
Alvotech ehf
Amgen Inc
Amrif BV
Amtixbio Co Ltd
Amytrx Therapeutics Inc
Annji Pharmaceutical Co Ltd
AnTolRx Inc
Apaxen
Apcegen Technologies Pvt Ltd
Applied Molecular Transport Inc
Aprilbio Co Ltd
Aprogen Inc
Aqilion AB
arGentis Pharmaceuticals LLC
Argenx SE
Arrien Pharmaceuticals LLC
Astellas Pharma Inc
AstraZeneca Plc
Atlanthera
Auransa Inc
Avesthagen Ltd
Avotres Inc
Axsome Therapeutics Inc
Axxam SpA
Bayer AG
Baylx Inc
Beijing Eastern Biotech Co Ltd
Beijing Hanmi Pharmaceutical Co Ltd
Beijing Sanyuan Gene Pharmaceutical Co Ltd
Beijing Toll Biotech Co Ltd
Beijing VDJBio Co Ltd
Bilix Co Ltd
Bio-Cancer Treatment International Ltd
Bio-Thera Solutions Ltd
Biocad
Biocon Ltd
Biogen Inc
Bioiberica SAU
Biois Corp
BioLingus AG
BioXpress Therapeutics SA
Biozeus Pharmaceutical SA
Brickell Biotech Inc
Bristol-Myers Squibb Co
BTB Pharma AB
C4X Discovery Holdings Plc
Can-Fite BioPharma Ltd
Captor Therapeutics SA
Carna Biosciences Inc
CEL-SCI Corp
Cellics Therapeutics Inc
Cellinbio Co Ltd
CELLnLIFE Inc
CellTex Therapeutics Corp
Celltrion Inc
Cellworks Group Inc
Celon Pharma SA
Centivax Inc
Centrymed Pharmaceutical Inc
CheckPoint Immunology Inc
Chengdu Hyperway Pharmaceuticals
Chengdu Jinrui Foundation Biotechnology Co Ltd
China Resources Pharmaceutical Group Ltd
Chong Kun Dang Pharmaceutical Corp
Citryll BV
Clevexel Pharma SA
Clover Biopharmaceuticals
Compugen Ltd
Cour Pharmaceuticals Development Co Inc
Creative Medical Technology Holdings Inc
Crossject SA
CrystalGenomics Inc
CSL Ltd
CSPC Pharmaceutical Group Ltd
cStem Regeneration Pharmaceutical Co Ltd
Cue Biopharma Inc
Cugene Inc
CV6 Therapeutics (Ni) Ltd
Cyclacel Pharmaceuticals Inc
Cyxone AB
Daewoong Pharmaceutical Co Ltd
Deka Biosciences Inc
DeMay Biotech
Denali Therapeutics Inc
Dendright Pty Ltd
Diamyd Medical AB
DiNonA Inc
DNX Biopharmaceuticals Inc
Domainex Ltd
Dr. Reddy's Laboratories Ltd
Ducentis BioTherapeutics Ltd
Dyadic International Inc
Dynavax Technologies Corp
Dyve Biosciences Inc
Egret Therapeutics Inc
EHL Bio Co Ltd
Eli Lilly and Co
Endpoint Health Inc
Enosi Life Sciences Corp
Ensign Pharmaceutical Inc
Enzene Biosciences Ltd
Enzychem Lifesciences Corp
EQRx Inc
Ergon Pharmaceuticals LLC
Eternity Bioscience Inc
Eton Pharmaceuticals Inc
Evotec SE
Exopharm Ltd
Eydis Bio Inc
f5 Therapeutics Inc
Forest Hills Partners Hong Kong Ltd
Foshan Rexie Biotechnology Co Ltd
Fresenius Kabi SwissBioSim GmbH
Future Medicine Co Ltd
Galapagos NV
GB Sciences Inc
Gbiologics Inc
GeneOne Life Science Inc
Generium
Generos Biomedical Technology (Hangzhou) Co Ltd
Genesen Co Ltd
Genor BioPharma Co Ltd
Genova Biotech Company Ltd
Genrix (Shanghai) Biopharmaceutical Co Ltd
Gilead Sciences Inc
Gismo Therapeutics Inc
GlaxoSmithKline Plc
GNT Pharma Co Ltd
Guangdong Yinzhu Pharmaceutical Technology Co Ltd
Guangdong Zhongsheng Pharmaceutical Co Ltd
Guangzhou BeBetter Medicine Technology Co Ltd
Guangzhou Jiayue Pharmaceutical Technology Co Ltd
H. Lundbeck AS
Han Wha Pharma Co Ltd
Hangzhou East China Pharmaceutical Group Co Ltd
Hanlim Pharm Co Ltd
Hebei Fitness Biotechnology Co Ltd
HEC Pharma Co Ltd
HK inno.N Corp
Hope Biosciences LLC
Horizon Therapeutics Plc
Hualan Biological Engineering Inc
HuniLife Biotechnology Inc
Hutchison MediPharma Ltd
I-Mab
iBio Inc
Ichnos Sciences Inc
ICM Co Ltd
Idogen AB
IL-2Rx Inc
Iltoo Pharma
IMBiologics Corp
IMD-Pharma SAS
Immungenetics AG
Immunwork Inc
Immupharma Plc
Immutep Ltd
Impetis Biosciences Ltd
InflammatoRx inc
Inmagene Biopharmaceuticals Ltd
Innovent Biologics Inc
Innovimmune Biotherapeutics Inc
Interprotein Corp
Intrinsic Medicine Inc
Io Therapeutics Inc
Istesso Ltd
Japan Tobacco Inc
Jeil Pharmaceutical Co Ltd
Jiangsu Carephar Pharmaceutical Co Ltd
Jiangsu Hengrui Medicine Co Ltd
Jiangsu Optixin Biomedical Technology Co Ltd
JiangSu Qyuns Therapeutics Co Ltd
Johnson & Johnson
Jubilant Therapeutics Inc
Jyant Technologies Inc
Kadmon Holdings Inc
Kangstem Biotech Co Ltd
KBP Biosciences Co Ltd
Kemmx Corp
Kezar Life Sciences Inc
Kidswell Bio Corp
KIMS Pharmaceutical Co Ltd
Kine Sciences
Kiniksa Pharmaceuticals Ltd
Korea United Pharm Inc
Kymera Therapeutics, Inc
L2 Diagnostics LLC
Landos Biopharma Inc
Lead Pharma Holding BV
Leukosight Inc
LG Chem Ltd
LipUm AB
LISCure Biosciences Co Ltd
Livzon Pharmaceutical Group Co Ltd
Longwood Biopharmaceuticals Co Ltd
Luckwel Pharmaceuticals Inc
Lupin Ltd
Lynk Pharmaceutical Hangzhou Co Ltd
Mabion SA
Mabpharm Ltd
Mabtech Ltd
Mabwell Shanghai Bioscience Co Ltd
Mabxience Holding SL
Maruho Co Ltd
medac GmbH
MedAnnex Ltd
MeiraGTx Holdings Plc
MENTRIK Biotech LLC
Merck & Co Inc
Mesoblast Ltd
MetiMedi Pharmaceuticals Co Ltd
MetrioPharm AG
Microbiotix Inc
Minghui Pharmaceutical (Shanghai) Co Ltd
Mirae Cell Bio Co Ltd
Mycenax Biotech Inc
MyeloRx LLC
MyMD Pharmaceuticals, Inc
Nano Intelligent Biomedical Engineering Corp
Nanode Therapeutics Inc
Nanolek LLC
Navigen Inc
NeuClone Pty Ltd
Neuracle Science Co Ltd
Nichi-Iko Pharmaceutical Co Ltd
North China Pharmaceutical Group New Drug Research and Development Co Ltd
NovaCell Technology Inc
NovalGen Ltd
Novartis AG
NuBioPharma LLC
Numab Therapeutics AG
Nurix Therapeutics Inc
Octagon Therapeutics Inc
Omeros Corp
Oncodesign SA
Oneness Biotech Co Ltd
Oryn Therapeutics
OSE Immunotherapeutics
Outlook Therapeutics Inc
Pahan Therapeutics
Paras Biopharmaceuticals Finland Oy
Parvus Therapeutics Inc
Peptinov SAS
Pfizer Inc
Pharmaceutical and Cosmetic Solutions Ltd
Pharmapraxis
PKU V-Ming (Hefei) Biologics Co Ltd
Promethera Biosciences SA
ProNoxis AB
Protab Ltd
Qilu Pharmaceutical Co Ltd
Qu Biologics Inc
R-Pharm
Radikal Therapeutics Inc
ReceptoPharm Inc
Regen BioPharma Inc
Regenerative Arthritis & Bone Medicine Inc
Reliance Life Sciences Pvt Ltd
Resolomics Ltd
Resverlogix Corp
Revolo Biotherapeutics Ltd
Rheos Medicines Inc
RheumaGen LLC
Ribomic Inc
Richter Gedeon Nyrt
Rigel Pharmaceuticals Inc
Rise Therapeutics LLC
Rophibio Inc
ROS Therapeutics ApS
Rottapharm Biotech Srl
Saje Pharma LLC
Santhera Pharmaceuticals Holding AG
Sareum Holdings Plc
SBI Biotech Co Ltd
SciRhom GmbH
Sengenics Corp Pte Ltd
Serene LLC
Servatus Ltd
SFA Therapeutics LLC
Shandong Danhong Pharmaceutical Co Ltd
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd
Shanghai Haiyan Pharmaceutical Technology Co Ltd
Shanghai Junshi Bioscience Co Ltd
Shanghai Novamab Biopharmaceuticals Co Ltd
Shanghai Pharmaceutical Group Co Ltd
Shenzhen Chipscreen Biosciences Co Ltd
Siam Bioscience Co Ltd
Sichuan Kelun Bio-Tech Pharmaceutical Co Ltd
Signablok Inc
Simcere Pharmaceutical Group Ltd
Singh Biotechnology LLC
SinoCelltech Group Ltd
SinoMab Bioscience Ltd
Sinsin Pharmaceutical Co Ltd
siRNAgen Therapeutics Corp
SK Chemicals Co Ltd
Sonoma Biotherapeutics Inc
Sorrento Therapeutics Inc
Splash Pharmaceuticals Inc
Statera Biopharma Inc
Suzhou Connect Biopharmaceuticals Ltd
Suzhou Everhealth Biomedical Co Ltd
Suzhou Sinovent Pharmaceuticals Co Ltd
Suzhou Zelgen Biopharmaceutical Co Ltd
SynAct Pharma AB
Synermore Biologics Co Ltd
Taiho Pharmaceutical Co Ltd
Takeda Pharmaceutical Co Ltd
Tasly Pharmaceutical Group Co Ltd
Teijin Pharma Ltd
TG Therapeutics Inc
The United Laboratories International Holdings Ltd
Tianjin Hemay Pharmaceutical Co Ltd
Tiziana Life Sciences Plc
TLL Pharmaceutical LLC
Tonix Pharmaceuticals Holding Corp
TPCera Ltd
trajectumPharma BV
Translational Biosciences
Triastek Inc
Tumorend LLC
Turgut Ilaclari AS
United Biomedical Inc
United BioPharma Inc
Vaccinex Inc
Vanworld Pharmaceutical (Rugao) Company Ltd
Vascular Biogenics Ltd
Vir Biotechnology Inc
Worg Pharmaceuticals Hangzhou Co Ltd
Wuhan Institute of Biological Products Co Ltd
Wuhan LL Science and Technology Development Co Ltd
Wuxi Fuxin Pharmaceutical Research and Development Co Ltd
Wyvern Pharmaceuticals Inc
Xalud Therapeutics Inc
XBiotech Inc
XL-protein GmbH
Y-Biologics Inc
Yantai Rongchang Pharmaceutical Co Ltd
Yichang Humanwell Pharmaceutical Co Ltd
Yuhan Corp
Zenas BioPharma (USA) LLC
Zhejiang Hisun Pharmaceutical Co Ltd
Zhejiang Yatai Pharmaceutical Co Ltd
Zhuhai United Laboratories Co Ltd
Zydus Lifesciences Ltd
ZyVersa Therapeutics Inc